Related references
Note: Only part of the references are listed.Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance
Prabhu Raj Joshi et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2017)
Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates
Huseyin-Agah Terzi et al.
SAUDI MEDICAL JOURNAL (2016)
Phenotypic Detection of Metallo-Beta-Lactamases in Carbapenem Resistant Acinetobacter baumannii Isolated from Pediatric Patients in Pakistan
Muneeza Anwar et al.
JOURNAL OF PATHOGENS (2016)
High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals
Khadidja Khorsi et al.
Asian Pacific Journal of Tropical Medicine (2015)
Detection of outbreak caused by multi-drug resistant Acinetobacter baumannii in Assiut University Hospitals
A. Daef Enas et al.
African Journal of Microbiology Research (2014)
Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance
Camila Rizek et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2014)
Prevalence of bla(NDM), bla(PER), bla(VEB), bla(IMP), and bla(VIM) Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran
Fatemeh Fallah et al.
SCIENTIFICA (2014)
High Prevalence of Metallo-beta-lactamase Producing Acinetobacter baumannii Isolated From Two Hospitals of Tehran, Iran
Maryam Noori et al.
ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES (2014)
Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons
Apostolos Liakopoulos et al.
BMC INFECTIOUS DISEASES (2013)
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
Dolores Sousa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Doripenem vs meropenem against Pseudomonas and Acinetobacter
K. Goyal et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2012)
blaIMP and blaVIM mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India
M. Shanthi Amudhan et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2012)
Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media
John D. Perry et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt
Martin Kaase et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Persistent Carriage and Infection by Multidrug-Resistant Escherichia coli ST405 Producing NDM-1 Carbapenemase: Report on the First Italian Cases
Marco Maria D'Andrea et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia et al.
LANCET INFECTIOUS DISEASES (2011)
Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance
Dustin King et al.
PROTEIN SCIENCE (2011)
Metallo-ß-Lactamases and Aptamer-Based Inhibition
Sara R. Schlesinger et al.
PHARMACEUTICALS (2011)
Global spread of New Delhi metallo-β-lactamase 1
Stephan Goettig et al.
LANCET INFECTIOUS DISEASES (2010)
Predictability of Doripenem Susceptibility in Acinetobacter baumannii Isolates Based on Other Carbapenem Susceptibilities and blaOXA Gene Status
John S. Esterly et al.
PHARMACOTHERAPY (2010)
Phenotypic and genotypic assays for detecting the prevalence of metallo-β-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital
R. Uma Karthika et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA
Vijaya B. Srinivasan et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2009)
Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU
Jung Hoon Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases
Matthew J. Ellington et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Prevalence of metallo-β lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India
Varsha Gupta et al.
JOURNAL OF INFECTION (2006)
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
L. Poirel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea
K Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii
C Héritier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp.
K Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance
AS Limansky et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Building communication networks: International network for the study and prevention of emerging antimicrobial resistance
HM Richet et al.
EMERGING INFECTIOUS DISEASES (2001)
Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from Northern Spain
L Gallego et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2001)
Share Paper
